Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | KIF11 | P52732 | 4/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.48 |
| ▸ | NR3C2 | P08235 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8809867 | 0.94 | KIF11 (0.61) | ALDH1A1SMN1; SMN2LMNAHPGDKDM4E | |
| SCHEMBL1449931 | 0.89 | PGR (0.67) | ALDH1A1SMN1; SMN2LMNAHPGDKDM4E | |
| SCHEMBL14358816 | 0.84 | KEAP1 (0.58) | ALDH1A1SMN1; SMN2LMNAHPGDKDM4E | |
| SCHEMBL14358814 | 0.84 | KEAP1 (0.58) | ALDH1A1SMN1; SMN2LMNAHPGDKDM4E | |
| SCHEMBL12054668 | 0.83 | KEAP1 (0.75) | ALDH1A1SMN1; SMN2LMNAHPGDKDM4E | |
| SCHEMBL5673137 | 0.83 | KEAP1 (0.56) | ALDH1A1SMN1; SMN2LMNAHPGDKDM4E | |
| SCHEMBL8017825 | 0.81 | KEAP1 (0.54) | ALDH1A1SMN1; SMN2LMNAHPGDKDM4E | |
| SCHEMBL15836266 | 0.79 | KEAP1 (0.52) | ALDH1A1SMN1; SMN2LMNAHPGDKDM4E | |
| SCHEMBL3554742 | 0.79 | KEAP1 (0.52) | ALDH1A1SMN1; SMN2LMNAHPGDKDM4E | |
| SCHEMBL3059778 | 0.79 | HPGD (0.66) | ALDH1A1SMN1; SMN2LMNAHPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119899122-A | Cyclobutylmethyl and phenyl substituted curcumin derivative and preparation method and application thereof | 常州大学 | 2025-04-29 | — | — | CN | claimed |
| CN-116283676-A | Curcumin derivative and preparation method and application thereof | 常州大学 | 2023-06-23 | — | — | CN | claimed |
| CN-119899122-A | Cyclobutylmethyl and phenyl substituted curcumin derivative and preparation method and application thereof | 常州大学 | 2025-04-29 | — | — | CN | disclosed |
| CN-116283676-B | Curcumin derivative and preparation method and application thereof | 常州大学 | 2025-03-28 | — | — | CN | disclosed |
| EP-2408454-B1 | NOVEL ANTI-INFLAMMATORY AGENTS | RESVERLOGIX CORP (CA) | 2024-07-24 | — | — | EP | disclosed |
| EP-2984072-B1 | SYNTHETIC ANALOGUES OF XANTHOHUMOL | UNIV PISA (IT) | 2024-05-29 | — | — | EP | disclosed |
| US-20240139131-A1 | SOTALOL COMPOSITIONS AND USES OF THE SAME | HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT | 2024-05-02 | — | — | US | disclosed |
| US-11850222-B2 | Sotalol compositions and uses of the same | ARBOR PHARMACEUTICALS, LLC (US) | 2023-12-26 | — | — | US | disclosed |
| US-11802135-B2 | Lysophosphatidic acid derivative | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2023-10-31 | — | — | US | disclosed |
| WO-2023154344-A1 | 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-08-17 | — | — | WO | disclosed |
| US-11718643-B2 | Multimodal anion exchange matrices | CYTIVA BIOPROCESS R&D AB (SE) | 2023-08-08 | — | — | US | disclosed |
| EP-0215124-B1 | SILVER HALIDE PHOTOGRAPHIC PHOTO-SENSITIVE MATERIAL | FUJI PHOTO FILM CO., LTD. (JP) | 1991-09-04 | — | — | EP | disclosed |
| EP-0435561-A2 | Silver halide photographic light-sensitive material | KONICA CORPORATION (JP) | 1991-07-03 | — | — | EP | disclosed |
| EP-0434413-A1 | Silver halide photographic light-sensitive material | KONICA CORPORATION (JP) | 1991-06-26 | — | — | EP | disclosed |
| EP-0401709-A2 | X-ray photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1990-12-12 | — | — | EP | disclosed |
| US-4925782-A | Silver halide photographic light-sensitive element containing water soluble dye compounds | FUJI PHOTO FILM CO., LTD. (JP) | 1990-05-15 | — | — | US | disclosed |
| US-4879204-A | HIGH CONTRAST | FUJI PHOTO FILM CO., LTD. (JP) | 1989-11-07 | — | — | US | disclosed |
| US-4764455-A | Color image-forming process | FUJI PHOTO FILM CO., LTD. (JP) | 1988-08-16 | — | — | US | disclosed |
| EP-0215124-A1 | SILVER HALIDE PHOTOGRAPHIC PHOTO-SENSITIVE MATERIAL | FUJI PHOTO FILM CO., LTD. (JP) | 1987-03-25 | — | — | EP | disclosed |
| US-3931142-A | Heterocyclic containing disazo compounds | CIBA-GEIGY AG (CH) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11802135-B2 | Lysophosphatidic acid derivative | LPAR4, LPAR2, LPAR1 | ALDH1A1 3134/4885SMN1; SMN2 3474/4885LMNA 1148/4885 |
| US-11718643-B2 | Multimodal anion exchange matrices | H1-3, H1-4, IGF2R | ALDH1A1 2226/4885SMN1; SMN2 3372/4885LMNA 1656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.